Literature DB >> 891293

Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.

D Crittenden, B L Tranum, A Haut.   

Abstract

A 43-year-old man with metastatic malignant melanoma was treated with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in combination with imidazole carboxamide and hydroxyurea. He achieved complete remission. After 22 months of chemotherapy, the patient developed bilateral pulmonary infiltrates. Open lung biopsy showed sclerosing alveolitis. Long-term therapy with BCNU may cause pulmonary fibrosis, as has been seen with other cytotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 891293     DOI: 10.1378/chest.72.3.372

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Lung damage from cytotoxic drugs.

Authors:  C H Collis
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

2.  The effect of paraquat on guanylate cyclase activity in relation to morphological changes of guinea pig lungs.

Authors:  S N Giri; G A Krishna
Journal:  Lung       Date:  1980       Impact factor: 2.584

Review 3.  Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications.

Authors:  D S Klein; P R Wilds
Journal:  Can Anaesth Soc J       Date:  1983-07

4.  Lung toxicity of lomustine in the treatment of progressive gliomas.

Authors:  Corinna Seliger; Christina Nürnberg; Wolfgang Wick; Antje Wick
Journal:  Neurooncol Adv       Date:  2022-05-10

5.  Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.

Authors:  Daniela A Bota; Annick Desjardins; Jennifer A Quinn; Mary L Affronti; Henry S Friedman
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.